SMITH ASSET MANAGEMENT GROUP LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$22,000
+22.2%
7000.0%0.00%0.0%
Q1 2021$18,000
-97.8%
700
-97.8%
0.00%
-97.9%
Q4 2020$807,000
+2.4%
32,068
-15.2%
0.05%
+14.6%
Q3 2020$788,000
-12.2%
37,798
-0.0%
0.04%
-16.3%
Q2 2020$898,000
+109.3%
37,808
+141.9%
0.05%
+226.7%
Q3 2019$429,000
-19.1%
15,627
-2.5%
0.02%
-16.7%
Q2 2019$530,000
-7.5%
16,027
-2.1%
0.02%
-5.3%
Q1 2019$573,000
+4.0%
16,366
-1.3%
0.02%0.0%
Q4 2018$551,000
-34.0%
16,577
-0.0%
0.02%
-20.8%
Q3 2018$835,000
-76.6%
16,581
-72.1%
0.02%
-76.7%
Q2 2018$3,562,000
+35.1%
59,521
+3.4%
0.10%
+18.4%
Q1 2018$2,637,000
+45.2%
57,571
+26.4%
0.09%
+52.6%
Q4 2017$1,816,000
-26.0%
45,562
-25.8%
0.06%
-30.5%
Q3 2017$2,455,000
-21.0%
61,367
-14.9%
0.08%
-13.7%
Q2 2017$3,109,000
-22.7%
72,129
-43.9%
0.10%
-18.1%
Q1 2017$4,023,000
+20.7%
128,520
-2.6%
0.12%
+18.4%
Q4 2016$3,332,000
-26.3%
131,971
-27.8%
0.10%
-26.3%
Q3 2016$4,520,000
+9.0%
182,791
-10.2%
0.13%
+7.3%
Q2 2016$4,148,000
+16.5%
203,613
-12.8%
0.12%
+17.0%
Q1 2016$3,562,000
+22162.5%
233,592
+19173.3%
0.11%
Q4 2015$16,0001,2120.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders